Previous 10 | Next 10 |
Summary ARK Invest’s 13F portfolio value decreased from $16.91B to $14.35B this quarter. UiPath, Ginkgo Bioworks, and NVIDIA were increased while decreasing Spotify, Ionis Pharma, CRISPR Therapeutics, and Coinbase Global. The top three positions are Tesla Inc., Zoom Vid...
Integrated single source solution tracks samples with whole blood as direct input Reduces sample mix-ups and need to re-run tests New offering to be highlighted at ASHG 2022 along with additional posters Twist Bioscience Corporation (NASDAQ: TWST), a comp...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has earned Great Place to Work ® Certification™ in the U.S. for the second ...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Steffen Hellmold, senior vice president, business development for data storage, will present a...
Think of the biggest, richest corporations on the planet. They all started out much smaller but grew enormously over time. Investors who spotted their potential early on made fortunes. We asked three Motley Fool contributors to pick monster stocks in the making that just might make inve...
Twist Bioscience (Nasdaq: TWST) and the Australian Research Council (ARC) Centre of Excellence in Synthetic Biology (CoESB) today announced a partnership that will enable CoESB members and partners to order a wide range of Twist products that facilitate research and development. Thi...
Enzolytics ( OTCPK:ENZC ) will work with Abveris, a division of Twist Bioscience ( NASDAQ: TWST ), on the discovery of monoclonal antibodies against several viruses . The initial focus is on antibodies targeting SARS-CoV-2. Terms call for Abveris (also known as...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience will present at the Baird 2022 Global...
Summary Twist Bioscience share price has fallen by 50% since the beginning of 2022. Management thinks DNA data storage could be $2 billion market for the company, aided by early mover advantage and investment in IP. Twist Bioscience recently raised full-year revenue guidance, ...
Gainers: Microvast Holdings ( MVST ) +19% . Hydrofarm Holdings Group ( HYFM ) +7% . Mammoth Energy Services ( TUSK ) +5% . Twist Bioscience ( TWST ) +5% . Certara ( CERT ) +5% . Losers: Bed Bath & Beyond ( BBBY ) ...
News, Short Squeeze, Breakout and More Instantly...
Twist Bioscience Corporation Company Name:
TWST Stock Symbol:
NASDAQ Market:
Twist Bioscience Corporation Website:
Pure Biologics’ exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today a...
Company to host conference call at 8:00 AM ET Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 th...
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of ...